IQVIA logo

IQVIA

IQVNYSEStock Fundamentals

IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services for the life sciences and healthcare industries. The company leverages its proprietary IQVIA Connected Intelligence platform and one of the world's largest collections of healthcare data to accelerate drug development and commercialization. Its core value proposition lies in integrating high-quality health data with specialized AI and domain expertise to improve patient outcomes and operational efficiency for healthcare stakeholders.

Market Cap$28.8B
Revenue TTM$16.6B
Net Income TTM$1.4B
P/E Ratio20.82
Net Margin8.33%
EPS TTM$8.05
Free Cash Flow TTM$2.1B
Employees88.0K
CEOAri Bousbib
CountryUnited States of America
Healthcare
Medical - Diagnostics & Research
SegmentsLife Sciences Tools & Services, Healthcare Technology, Biotechnology, Pharmaceuticals
Business ModelsSubscription SaaS, Professional Services, Data-as-a-Service, Outsourcing
Most Recent EarningsMay 5, 2026 · 15 days agoQ1 2026
View report
Next EarningsJul 28, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Gross Margin32.99%
Op. Margin13.23%
ROE22.71%
D/E258.24%
Current Ratio0.747
Total Debt$16.1B
Cash$1.9B
CapEx TTM$588.0M

Gross Profit

View metric

Net Income

View metric

Operating Cash Flow

View metric

Free Cash Flow

View metric

EPS (Diluted)

View metric

Business Segments

Research & Development Solutions

primary

Offers comprehensive clinical trial services including project management, clinical monitoring, and laboratory services. It utilizes analytics-driven clinical development to optimize trial design, site selection, and patient recruitment.

Products

Avacare Clinical Research Network, Decentralized Clinical Trials, Central Laboratory Services, Genomic Services, Bioanalytical Services

Customers

Biopharmaceutical companies, Medical researchers, Biotech firms

Technology & Analytics Solutions

major

Provides cloud-based software applications, real-world evidence platforms, and strategic consulting services. This segment helps clients manage clinical and commercial operations through data-driven insights and orchestrated technology workflows.

Products

IQVIA Connected Intelligence, Healthcare-grade AI, Global Market Insight, MIDAS, Analytics Link, Disease Insights, IQVIA Health Data Catalog

Customers

Pharmaceutical companies, Biotechnology companies, Medical device companies, Government agencies, Payers

Contract Sales & Medical Solutions

moderate

Provides healthcare provider engagement and patient support services to assist in the commercialization of medical treatments. This includes deploying contract sales forces and nurse-based patient education programs.

Products

Health Care Provider Engagement Services, Patient Engagement Services, Medical Services, eHealth multichannel interactions

Customers

Biopharmaceutical companies, Medical device companies, Pharmacies

Segment Financials

Research & Development Solutions — Revenue

View metric

Research & Development Solutions — Cost of revenues, exclusive of depreciation and amortization

View metric

Research & Development Solutions — Segment profit

View metric

Europe and Africa — Revenue

View metric

Asia-Pacific — Revenue

View metric

Commercial Solutions — Business combinations

View metric

Commercial Solutions — Revenue

View metric

Commercial Solutions — Segment profit

View metric

Business Overview

Competitive Position

A global leader in healthcare intelligence and clinical research, distinguished by a massive proprietary longitudinal patient data set and integrated AI-powered technology platforms.

Geographies

Global, North America, Asia, Europe, Emerging Markets

Customer Segments

Biopharmaceutical Companies, Government Agencies, Healthcare Providers, Payers

Upstream Dependencies

Data suppliers, Cloud infrastructure providers, Laboratory equipment manufacturers, Software developers

Downstream Customers

Top 100 global pharmaceutical companies, Biotechnology startups, Public health organizations, Medical device manufacturers, Health systems and providers

IQVIA logo

IQVIA FAQ

Common questions about IQVIA

IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services for the life sciences and healthcare industries. The company leverages its proprietary IQVIA Connected Intelligence platform and one of the world's largest collections of healthcare data to accelerate drug development and commercialization. Its core value proposition lies in integrating high-quality health data with specialized AI and domain expertise to improve patient outcomes and operational efficiency for healthcare stakeholders.

IQVIA (IQV) has a market capitalization of $28.8B and trades on NYSE.

IQVIA generated $16.6B in trailing twelve-month revenue with net income of $1.4B, representing a net margin of 8.3%. Gross margin stands at 33.0%, with free cash flow of $2.1B. These figures are based on the Q1 2026 filing.

IQVIA's key competitors include Veeva Systems, Cognizant Technology Solutions, Labcorp Holdings Inc., and others. These companies compete in similar markets and product categories.

IQVIA has approximately 88,000 employees.